July 17, 2018 / 4:54 AM / in a year

Swiss stocks - Factors to watch on July 17

ZURICH, July 17 (Reuters) - The Swiss blue-chip SMI was seen opening nearly unchanged at 8,854 points on Tuesday, according to premarket indications by bank Julius Baer .

Here are some of the main factors that may affect Swiss stocks:


The Swiss bank has hired Citigroup’s Mathieu Salas to head its coverage of financial technology clients, according to an internal memo, the contents of which were confirmed by a spokeswoman for the European bank.


The Swiss drugmaker said on Tuesday its investigational drug baloxavir marboxil reduced symptoms in people at high risk of complications from flu, a boost to its efforts to win approval for the single-dose, oral anti-viral medicine and to help remedy falling sales of its older, patent-expired Tamiflu medicine that is being challenged by generics.


* Panalpina said first-half profit rose to 36.1 million Swiss francs, with CEO Stefan Karlen saying the freight forwarding and logistics company is “on track.” It is also buying a majority stake in perishables specialist Skyservices.

* CEVA Logistics said it expects French shipping company CMA CGM to convert securities into ordinary shares within the next four weeks, giving it a nearly 25 percent stake in the Swiss-listed logistics company.

* Energiedienst Holding said that operating profit as of June 30 came in below the previous year, as the company blamed capital market headwinds.

* Schlatter Group said it increased net sales and profit for the first half.

* OC Oerlikon deepened its cooperation with RUAG for 3D printed components for space, according to a pact to be signed on Tuesday at the big Farnborough Airshow.

* Zuger Kantonalbank said its first-half profit rose 9.5 percent to 34.2 million Swiss francs.

* Bell Food Group said first-half operating profit fell some 10 million francs, compared to the year-earlier period.

* Leclanche said it had consolidated its debt with a single lender and simplified its debt structure.

* Zehnder is buying Finnish-based Enervent for an undisclosed price.

Reporting by Zurich newsroom

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below